TLR7/8/9 agonists and low-dose cisplatin synergistically promotes tertiary lymphatic structure formation and antitumor immunity
2025 · npj Vaccines · 10 citations
https://doi.org/10.1038/s41541-024-01055-z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
177
Citations
8
h-index
7
i10-index
Yiwei Zhong is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Immune Cell Function and Interaction & Respiratory viral infections research. The author has an h-index of 8, co-authored 13 publications.
https://doi.org/10.1038/s41541-024-01055-z
https://doi.org/10.1080/21645515.2015.1072660
Click to start Chat